Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Dubsmash on the deal. Dubsmash, a lip-syncing video application, announced its acquisition by Reddit. Reddit is an...
Reddit’s Acquisition Of Dubsmash
4D Molecular Therapeutics’ $193.2 Million Initial Public Offering
Latham & Watkins LLP advised 4D Molecular Therapeutics on the deal. 4D Molecular Therapeutics, Inc. (4DMT), a clinical-stage gene therapy company harnessing the power of directed...
TRU Precious Metals Corp.’s Acquisition Of Stony Lake Property
Wildeboer Dellelce LLP acted as legal counsel to TRU. TRU Precious Metals Corp. (TSXV: TRU) has completed the indirect acquisition of a mineral license for the...
Novartis’ $770 Million Acquisition Of Cadent Therapeutics
Goodwin Procter LLP advised Cadent Therapeutics on the deal. Cadent Therapeutics announced its definitive agreement with Novartis, under which Novartis will acquire all of the outstanding...
Eli Lilly’s $1.040 Billion Acquisition of Prevail Therapeutics
Weil, Gotshal & Manges LLP acted as legal counsel to Lilly, while Ropes & Gray LLP and Cooley LLP acted as legal counsel to Prevail on...
AlpInvest Secondaries Program VII’s $9 Billion Fundraising
Ropes & Gray advised AlpInvest Partners on the deal. AlpInvest Partners, The Carlyle Group’s dedicated private equity primary fund, co-investment, and secondary solutions platform, has raised...
Tempus’ $200 Million G-2 Financing
Wilson Sonsini Goodrich & Rosati advised Tempus on the deal. Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare,...
The Green Organic Dutchman’s C$15 Million ATM Equity Program
Torys LLP represented TGOD on the operation. The Green Organic Dutchman Holdings Ltd. announced that it established an at-the-market equity program allowing the company to issue...
JW Asset Management, LLC’s $20 Million Investment in Gage Cannabis Co.
Cassels assisted JW Asset Management. Gage Cannabis Co., the leading high-quality craft cannabis brand and operator in Michigan, announced it has secured a minimum investment of...
Rocket Pharmaceuticals’ $260 Million Upsized Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Rocket Pharmaceuticals, Inc. has announced the pricing of an upsized underwritten public offering of 4,642,858 shares...
Certara’s $336.5 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Certara, Inc. (Certara), a global leader in biosimulation, has announced the pricing of its upsized initial...
BridgeBio Pharma’s Joint venture With Maze Therapeutics
Goodwin Procter LLP advised BridgeBio Pharma on the deal. BridgeBio Pharma (Nasdaq: BBIO) announced the establishment of its joint venture with Maze Therapeutics, Contour Therapeutics, which...